AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities on Patient Outcomes After Invasive Mechanical Ventilation and Vasopressor Therapy in the ICU

RecruitingNAAges 18 Years - anyAllNantes University Hospital
💬

In plain words

What the trial is, and whether it could suit you

The NUTRIREA-4 trial will test the hypothesis that an individually tailored rehabilitation program combining nutritional therapy, physiotherapy, and physical activity and started early in the ICU then continued uninterruptedly throughout the post-ICU stay and at home after hospital discharge improves the long-term outcomes of critical-illness survivors, compared to usual care. From ICU admission to recovery at home, the trial patients will receive either usual care or the early extended rehabilitation program. Usual care will consist in nutritional support and physiotherapy according to usual local practice in each participating ICU. The early extended program will consist of nutritional therapy, physiotherapy, and physical activity according to a standardized protocol tailored to general- and muscle-health improvements achieved in each individual patient over time.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Invasive mechanical ventilation (MV) started in the ICU within the past 24 h, or started before ICU admission with ICU admission within the past 24 h, and expected to be required for at least 48 hours after randomization * Treatment with a vasoactive agent for shock (adrenaline, dobutamine, or noradrenaline) * Nutritional support expected to be started within 24 h after intubation (or within 24 h after ICU admission if intubation occurred before ICU admission) * Age 18 or older * Patient and/or next-of-kin informed about the trial and having consented to participation in the trial. If the patient is unable to receive information and no next-of-kin can be contacted during screening for the trial, trial inclusion will be completed as an emergency procedure by the ICU physician, in compliance with French law. * Covered by the French public health-insurance system Exclusion Criteria: * MV started more than 24 hours earlier * Specific nutritional needs, such as pre-existing long-term home enteral or parenteral nutrition for chronic bowel disease * Dying patient, do-not-resuscitate order, or other treatment- limitation decision at ICU admission * Social circumstances hindering follow-up and telephone/video consultations (no fixed address, non-European residence) * Inability to provide a stable personal mobile phone number (temporary number or not in the owner's name) * Communication difficulties via telephone or video consultation (pre-existing severe hearing or visual impairment) * Pre-existing chronic illness with life expectancy \<6 months * Pre-existing cognitive impairment * Pre-existing spinal injury * Inability to walk before the critical illness * Acute or chronic neuromuscular disease * Brain injury, e.g., due to cardiac arrest, stroke, or severe trauma * Pregnancy, recent delivery, or lactation * Adult under guardianship * Correctional facility inmate * Institutionalized patient * Prior inclusion in a randomized trial designed to compare rehabilitation programs delivered to patients during critical illness
💊

What it tests

  • Rehabilitation group
  • Control group
📍

Where

52 sites
CH d'Albi
Albi, France
CHU d'Amiens - Site Sud
Amiens, France
CHU d'Amiens
Amiens, France
CHU d'Angers
Angers, France
CH d'Angoulème
Angoulême, France
CH d'Argenteuil
Argenteuil, France
CH de Belfort
Belfort, France
CHU de Besançon
Besançon, France

…and 44 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy